
Article 1 

1. The derogation from mutual recognition proposed by Poland, namely the refusal to grant an authorisation, for the biocidal product referred to in paragraph 2 is justified on the grounds of protection of the health and life of humans, as referred to in point (c) of Article 37(1) of Regulation (EU) No 528/2012.
2. Paragraph 1 applies to the biocidal product identified by the following case number, as provided for by the Register for Biocidal Products:BC-SV012547-08.
Article 2 
This Decision is addressed to the Republic of Poland.
Done at Brussels, 25 November 2019.
For the Commission
Vytenis ANDRIUKAITIS
Member of the Commission